SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001562180-20-001865
Filing Date
2020-03-02
Accepted
2020-03-02 16:02:53
Documents
2
Period of Report
2020-02-27

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 4  
1 PRIMARY DOCUMENT primarydocument.xml 4 4113
2 KAUFMANN - POWER OF ATTORNEY kaufmann-16poa.txt EX-24 3506
  Complete submission text file 0001562180-20-001865.txt   9132
Mailing Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109
Business Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109 857-246-8998
PIERIS PHARMACEUTICALS, INC. (Issuer) CIK: 0001583648 (see all company filings)

IRS No.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address C/O PIERIS PHARMACEUTICALS, INC. 255 STATE STREET, 9TH FLOOR BOSTON MA 02109
Business Address
Kaufmann Hitto (Reporting) CIK: 0001787104 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37471 | Film No.: 20676748